Touchstone Healthcare & Biotechnology C
303 Broadway Suite 1100 Cincinnati OH 45202
Map
Phone: 800-543-0407
| Category: | Health | | Fund Family: | Touchstone | | Net Assets: | 3.20M | | Year-to-Date Return: | 0.68% | | Yield: | 0.00% | | Morningstar Rating: |  | | Fund Inception Date: | 20-Nov-06 |
|
Frank L. Sustersic
Lead Manager since
28-Feb-01 | | | Sustersic is a senior portfolio manager with Turner Investment Partners, his employer since 1994. Prior to 1994, he was an investment officer/fund manager with First Fidelity Bank Corporation. He has 17 years investment experience. Sustersic holds the Chartered Financial Analyst designation. |
| Min Initial Investment: | $2,500 | | Min Initial Investment, IRA: | $1,000 | | Min Initial Investment, AIP: | $100 | | Min Subsequent Investment: | $50 | | Min Subsequent Investment, IRA: | $50 | | Min Subsequent Investment, AIP: | $50 |
|
| |
| The investment seeks long term capital appreciation. The funds invests at least 80% of assets in common stocks of healthcare and biotechnology companies that are traded in the U.S.. It typically invests in the common stocks of medium to large capitalization companies, but may also invest in companies of any size. These securities may be traded over the counter or listed on an exchange. The fund may engage in frequent and active trading of securities. It is nondiversified. |
| Last Dividend
| YFT_NOT_APPLICABLE_ABBREVIATION | | Last Cap Gain
(18-Dec-07):
| 1.98 | | Annual Holdings Turnover
| 127.00% | | Average for Category:
| 134.64% |
|
| Expense | THBFX | Category
Avg | | Total Expense Ratio: | 2.30%
| 1.68% | | Max 12b1 Fee: | 1.00%
| N/A | | Max Front End Sales Load: | %
| 5.35% | | Max Deferred Sales Load: | 1.00%
| 2.88% | | 3 Yr Expense Projection*: |
$ 788 | $720 | | 5 Yr Expense Projection*: |
$ 1,370 | $1,077 | | 10 Yr Expense Projection*: |
$ 2,948 | $2,106 |
|
|
1.23% Nasdaq 
Profile
